Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Thalassemia: genotypes and phenotypes.

D Loukopoulos1

  • 1First Department of Medicine, University of Athens, Greece.

Annals of Hematology
|April 1, 1991
PubMed
Summary

Genetic defects explain the diverse symptoms of thalassemia. Advances in molecular technology link specific gene mutations and deletions to the severity of alpha and beta thalassemia, impacting globin mRNA production.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Fetal Erythropoiesis after Allogeneic Bone Marrow Transplantation Estimated by the Peripheral Blood Erythrocytes Containing Hemoglobin F (F-cells).

Hematology (Amsterdam, Netherlands)·2016
Same author

No evidence of frequent association of the JAK2 V617F mutation with acute myocardial infarction in young patients.

Leukemia·2009
Same author

Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia.

Kidney international·2006
Same author

Ethical issues: should we give the predictive genetic profile to the citizens?

Clinical chemistry and laboratory medicine·2003
Same author

Genetic heterogeneity underlies juvenile hemochromatosis phenotype: analysis of three families of northern Greek origin.

Blood cells, molecules & diseases·2002
Same author

Elastic tissue abnormalities in inherited haemolytic syndromes.

European journal of clinical investigation·2002

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Thalassemia exhibits significant phenotypic heterogeneity.
  • Recent molecular technology advances have clarified the genetic underpinnings of thalassemia.
  • Understanding these genetic defects is crucial for diagnosis and management.

Purpose of the Study:

  • To correlate the phenotypic heterogeneity of thalassemia with specific genomic defects.
  • To elucidate the molecular mechanisms underlying different thalassemia types (alpha and beta).
  • To establish a quantitative relationship between functional globin mRNA levels and disease severity.

Main Methods:

  • Analysis of gene deletions (complete and partial) and point mutations within globin genes and flanking DNA.
  • Assessment of molecular mechanisms affecting gene expression, including transcription, RNA processing, and translation.
  • Quantification of functional globin chain mRNA available to ribosomes.

Main Results:

  • Genomic defects, including deletions and point mutations, directly correlate with thalassemia phenotypes.
  • Disease severity is quantitatively related to the amount of functional globin chain mRNA, ranging from absent to subnormal levels.
  • Specific mutations (e.g., frameshift, nonsense, splice-site) result in zero functional mRNA, while others lead to reduced mRNA levels.
  • Hyper-unstable globin chains can also cause a thalassemic phenotype.
  • Beta-thalassemia severity is influenced by the capacity for gamma-chain synthesis reactivation and hemoglobin F production.

Conclusions:

  • Genomic defects are the primary determinants of thalassemia's phenotypic variability.
  • The level of functional globin mRNA is a key quantitative factor in thalassemia severity.
  • Understanding the molecular basis of thalassemia aids in predicting disease phenotype and potential compensatory mechanisms.

Related Experiment Videos